Compulsive drug use linked to sensitized ventral striatal dopamine transmission.

Development and validation of brief measures of positive and negative affect: The PANAS scales.

Watson, D., Clark, L. A., & Tellegen, A. (1988) · Journal of Personality and Social Psychology · doi:10.1037/0022-3514.54.6.1063 · Cited by 32,433 · see citing works

The neural basis of drug craving: An incentive-sensitization theory of addiction

Robinson, T. (1993) · Brain Research Reviews · doi:10.1016/0165-0173(93)90013-p · Cited by 7,346 · see citing works

Behavioral inhibition, behavioral activation, and affective responses to impending reward and punishment: The BIS/BAS scales

Carver, C. S., & White, T. L. (1994) · Journal of Personality and Social Psychology · doi:10.1037/0022-3514.67.2.319 · Cited by 7,306 · see citing works

A psychobiological model of temperament and character

Cloninger, C. R. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820240059008 · Cited by 5,458 · see citing works

Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats.

Di Chiara, G., & Imperato, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5274 · Cited by 4,733 · see citing works

A psychomotor stimulant theory of addiction.

Wise, R. A., & Bozarth, M. A. (1987) · Psychological Review · doi:10.1037/0033-295x.94.4.469 · Cited by 2,747 · see citing works

Untitled work

(1994) · Cited by 2,675 · see citing works

Recent Developments in Parkinson's Disease

Hurtig, H. I. (1987) · Neurology · doi:10.1212/wnl.37.5.893 · Cited by 1,926 · see citing works

Behavioral expressions and biosocial bases of sensation seeking

Corr, P. J. (1995) · Personality and Individual Differences · doi:10.1016/0191-8869(95)90059-4 · Cited by 1,525 · see citing works

The psychology and neurobiology of addiction: an incentive–sensitization view

Robinson, T. E., & Berridge, K. C. (2000) · Addiction · doi:10.1046/j.1360-0443.95.8s2.19.x · Cited by 1,507 · see citing works

Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies

Vanderschuren, L. J. M. J., & Kalivas, P. W. (2000) · Psychopharmacology · doi:10.1007/s002130000493 · Cited by 1,337 · see citing works

Conditioned place preference: what does it add to our preclinical understanding of drug reward?

Bardo, M. T., & Bevins, R. A. (2000) · Psychopharmacology · doi:10.1007/s002130000569 · Cited by 1,233 · see citing works

Parametric Imaging of Ligand-Receptor Binding in PET Using a Simplified Reference Region Model

Gunn, R. N., Lammertsma, A. A., Hume, S. P., & Cunningham, V. J. (1997) · NeuroImage · doi:10.1006/nimg.1997.0303 · Cited by 1,085 · see citing works

Decreased dopamine D₂ receptor availability is associated with reduced frontal metabolism in cocaine abusers

Volkow, N. D., Fowler, J. S., Wang, G., Hitzemann, R., Logan, J., Schlyer, D. J., Dewey, S. L., & Wolf, A. P. (1993) · Synapse · doi:10.1002/syn.890140210 · Cited by 924 · see citing works

Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient

Piccini, P. P., Brooks, D. J., Björklund, A., Gunn, R. N., Grasby, P. M., Rimoldi, O. E., Brundin, P., Hagell, P., Rehncrona, S., Widner, H., et al. (1999) · Nature Neuroscience · doi:10.1038/16060 · Cited by 700 · see citing works

Childhood Personality Predicts Alcohol Abuse in Young Adults

Cloninger, C. R., Sigvardsson, S., & Bohman, M. (1988) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1988.tb00232.x · Cited by 694 · see citing works

Automated three‐dimensional registration of magnetic resonance and positron emission tomography brain images by multiresolution optimization of voxel similarity measures

Studholme, C., Hill, D., & Hawkes, D. J. (1997) · Medical Physics · doi:10.1118/1.598130 · Cited by 675 · see citing works

Psychobiology of novelty seeking and drug seeking behavior

Bardo, M. T., Donohew, R. L., & Harrington, N. G. (1996) · Behavioural Brain Research · doi:10.1016/0166-4328(95)00203-0 · Cited by 667 · see citing works

Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies

Giovannoni, G. (2000) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.68.4.423 · Cited by 587 · see citing works

Decision-making and addiction (part II): myopia for the future or hypersensitivity to reward?

Bechara, A., Dolan, S., & Hindes, A. (2002) · Neuropsychologia · doi:10.1016/s0028-3932(02)00016-7 · Cited by 580 · see citing works

Pathological Gambling Caused by Drugs Used to Treat Parkinson Disease

Dodd, M. L., Klos, K. J., Bower, J. H., Geda, Y. E., Josephs, K. A., & Ahlskog, J. E. (2005) · Archives of Neurology · doi:10.1001/archneur.62.9.noc50009 · Cited by 563 · see citing works

Personality and substance use disorders: A prospective study.

Sher, K. J., Bartholow, B. D., & Wood, M. D. (2000) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.68.5.818 · Cited by 483 · see citing works

Amphetamine-induced increases in extracellular dopamine, drug wanting, and novelty seeking: a PET/[11C] raclopride study in healthy men

Leyton, M. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00366-4 · Cited by 476 · see citing works

Punding in Parkinson's disease: Its relation to the dopamine dysregulation syndrome

Evans, A. H., Katzenschlager, R., Paviour, D. C., O’Sullivan, J. D., Appel, S., Lawrence, A. D., & Lees, A. J. (2004) · Movement Disorders · doi:10.1002/mds.20045 · Cited by 474 · see citing works

BIS/BAS levels and psychiatric disorder: An epidemiological study

Johnson, S. L., Turner, R. J., & Iwata, N. (2003) · Journal of Psychopathology and Behavioral Assessment · doi:10.1023/a:1022247919288 · Cited by 458 · see citing works

Incentive Sensitization by Previous Amphetamine Exposure: Increased Cue-Triggered “Wanting” for Sucrose Reward

Wyvell, C. L., & Berridge, K. C. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-19-07831.2001 · Cited by 436 · see citing works

Punding in Parkinson's disease: Its relation to the dopamine dysregulation syndrome

Evans, A., Katzenschlager, R., Paviour, D. C., Appel‐Cresswell, S., Lawrence, A., & Lees, A. J. (2004) · UCL Discovery (University College London) · Cited by 401 · see citing works

Pathological gambling associated with dopamine agonist therapy in Parkinson’s disease

Driver‐Dunckley, E. D., Samanta, J., & Stacy, M. A. (2003) · Neurology · doi:10.1212/01.wnl.0000076478.45005.ec · Cited by 317 · see citing works

Cocaine Dependence and D2 Receptor Availability in the Functional Subdivisions of the Striatum: Relationship with Cocaine-Seeking Behavior

Martinez, D., Broft, A., Foltin, R. W., Slifstein, M., Hwang, D.-R., Huang, Y., Perez, A., Frankel, W. G., Cooper, T., Kleber, H. D., et al. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300420 · Cited by 306 · see citing works

Compulsive use of dopamine replacement therapy in Parkinson's disease: reward systems gone awry?

Lawrence, A. D., Evans, A. H., & Lees, A. J. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00529-5 · Cited by 280 · see citing works

Dopamine dysregulation syndrome in Parkinson's disease

Evans, A. H., & Lees, A. J. (2004) · Current Opinion in Neurology · doi:10.1097/01.wco.0000137528.23126.41 · Cited by 257 · see citing works

Relationship between reward-enhancing and stereotypical effects of psychomotor stimulant drugs

ROBBINS, T. W. (1976) · Nature · doi:10.1038/264057a0 · Cited by 241 · see citing works

Neural and psychological mechanisms underlying appetitive learning: links to drug addiction

Cardinal, R. N., & Everitt, B. J. (2004) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2004.03.004 · Cited by 218 · see citing works

Motivational deficits after brain injury: effects of bromocriptine in 11 patients.

Powell, J. H., Al‐Adawi, S., Morgan, J., & Greenwood, R. (1996) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.60.4.416 · Cited by 213 · see citing works

Factors influencing susceptibility to compulsive dopaminergic drug use in Parkinson disease

Evans, A. H., Lawrence, A. D., Potts, J., Appel, S., & Lees, A. J. (2005) · Neurology · doi:10.1212/01.wnl.0000184487.72289.f0 · Cited by 207 · see citing works

Endogenous dopamine release after pharmacological challenges in Parkinson's disease

Piccini, P., Pavese, N., & Brooks, D. (2003) · Annals of Neurology · doi:10.1002/ana.10526 · Cited by 157 · see citing works

Individual Differences in Behavioral and Subjective Responses to Alcohol

de Wit, H., UHLENHUTH, E. H., Pierri, J. N., & Johanson, C. E. (1987) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1987.tb01263.x · Cited by 132 · see citing works

Relationship between craving and personality in treatment-seeking women with substance-related disorders

Zilberman, M. L., Tavares, H., & el‐Guebaly, N. (2003) · BMC Psychiatry · doi:10.1186/1471-244x-3-1 · Cited by 120 · see citing works

Mini-Mental Parkinson: First Validation Study of a New Bedside Test Constructed for Parkinson’s Disease

Mahieux, F., Michelet, D., Manifacier, M.-J., Boller, F., Fermanian, J., & Guillard, A. (1995) · Behavioural Neurology · doi:10.1155/1995/304876 · Cited by 116 · see citing works

Facilitation of sexual behavior in male rats following d -amphetamine-induced behavioral sensitization

Fiorino, D. F., & Phillips, A. G. (1999) · Psychopharmacology · doi:10.1007/s002130050880 · Cited by 110 · see citing works

Concurrent Activation of Dopamine D1and D2Receptors Is Required to Evoke Neural and Behavioral Phenotypes of Cocaine Sensitization

Capper-Loup, C., Canales, J. J., Kadaba, N., & Graybiel, A. M. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-14-06218.2002 · Cited by 108 · see citing works

Chronic intermittent amphetamine pretreatment enhances future appetitive behavior for drug- and natural-reward: interaction with environmental variables

Nocjar, C., & Panksepp, J. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00321-7 · Cited by 106 · see citing works

Paradoxical reinforcing properties of apomorphine: Effects of nucleus accumbens and area postrema lesions

van der Kooy, D., Swerdlow, N. R., & Koob, G. F. (1983) · Brain Research · doi:10.1016/0006-8993(83)91071-5 · Cited by 100 · see citing works

The Natural History of Parkinson’s Disease in the Pre-Levodopa and Post-Levodopa Eras

Hoehn, M. M. M. (1992) · Neurologic Clinics · doi:10.1016/s0733-8619(18)30213-5 · Cited by 95 · see citing works

Mini-Mental Parkinson: first validation study of a new bedside test constructed for Parkinson's disease.

Mahieux, F., Michelet, D., Manifacier, M.-J., et al. (1995) · PubMed · doi:10.3233/ben-1995-8102 · Cited by 89 · see citing works

The Tridimensional Personality Questionnaire as a Predictor of Relapse in Detoxified Alcohol Dependents

Meszaros, K., Lenzinger, E., Hornik, K., Füreder, T., Willinger, U., Fischer, G., Schönbeck, G., Aschauer, H. N., & on behalf of The European Fluvoxamine in Alcoholism Study Group (1999) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1999.tb04141.x · Cited by 82 · see citing works

The Rate of Intravenous Cocaine Administration Determines Susceptibility to Sensitization

Samaha, A., Li, Y., & Robinson, T. E. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-08-03244.2002 · Cited by 76 · see citing works

Psychiatric aspects in Parkinsonism treated with L-dopa

Damásio, A. R., Lobo-Antunes, J., & Macedo, C. (1971) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.34.5.502 · Cited by 75 · see citing works

Recognition of a dopamine replacement therapy dependence syndrome in Parkinson's disease: a pilot study☆☆Supplementary

Bearn, J., Evans, A. H., Kelleher, M., Turner, K., & Lees, A. J. (2004) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2004.06.005 · Cited by 52 · see citing works

Which Adolescents Are Most Receptive to Tobacco Industry Marketing? Implications for Counter-Advertising Campaigns

Audrain-McGovern, J. E., Tercyak, K. P., Shields, A. E., Bush, A., Espinel, C. F., & Lerman, C. E. (2003) · Health Communication · doi:10.1207/s15327027hc1504_07 · Cited by 32 · see citing works

L-dopa, behavioral activation and psychopathology.

Dl, M. (1972) · PubMed · Cited by 30 · see citing works

Conditioned Place Preference Induced by a Combination of l-Dopa and a COMT Inhibitor, Entacapone, in Rats

Katajamäki, J., Honkanen, A., Piepponen, P. T., Lindén, I., Zharkovsky, A., & Ahtee, L. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(97)00394-8 · Cited by 17 · see citing works

The debate over dopamine’s role in reward: the case for incentive salience

Berridge, K. C. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0578-x · Cited by 2,347 · see citing works

Dissecting components of reward: ‘liking’, ‘wanting’, and learning

Berridge, K. C., Robinson, T. E., & Aldridge, J. W. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2008.12.014 · Cited by 1,942 · see citing works

Pleasure Systems in the Brain

Berridge, K. C., & Kringelbach, M. L. (2015) · Neuron · doi:10.1016/j.neuron.2015.02.018 · Cited by 1,730 · see citing works

The incentive sensitization theory of addiction: some current issues

Robinson, T. E., & Berridge, K. C. (2008) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2008.0093 · Cited by 1,717 · see citing works

Liking, wanting, and the incentive-sensitization theory of addiction

Berridge, K. C., & Robinson, T. E. (2016) · American Psychologist · doi:10.1037/amp0000059 · Cited by 1,440 · see citing works

Affective neuroscience of pleasure: reward in humans and animals

Berridge, K. C., & Kringelbach, M. L. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1099-6 · Cited by 1,254 · see citing works

From prediction error to incentive salience: mesolimbic computation of reward motivation.

Berridge, K. C. (2012) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2012.07990.x · Cited by 700 · see citing works

Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation

Thobois, S., Ardouin, C., Lhommée, E., Klinger, H., Lagrange, C., Xie, J., Fraix, V., Braga, M.-C. C., Hassani, R., Kistner, A., et al. (2010) · Brain · doi:10.1093/brain/awq032 · Cited by 519 · see citing works

Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study

Steeves, T. D. L., Miyasaki, J., Zurowski, M., Lang, A. E., Pellecchia, G., Van Eimeren, T., Rusjan, P., Houle, S., & Strafella, A. P. (2009) · Brain · doi:10.1093/brain/awp054 · Cited by 502 · see citing works

New developments in human neurocognition: clinical, genetic and brain imaging correlates of impulsivity and compulsivity

Fineberg, N. A., Chamberlain, S. R., Goudriaan, A. E., Stein, D. J., Vanderschuren, L. J. M. J., Gillan, C. M., Shekar, S., Gorwood, P. A. P. M., Voon, V., Morein-Zamir, S., et al. (2014) · CNS Spectrums · doi:10.1017/s1092852913000801 · Cited by 488 · see citing works

Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease

Bastide, M. F., Meissner, W. G., Picconi, B., Fasano, S., Fernagut, P., Feyder, M. T., Francardo, V., Alcacer, C., Ding, Y., Brambilla, R., et al. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.07.002 · Cited by 470 · see citing works

Parkinson's disease: The quintessential neuropsychiatric disorder

Weintraub, D. A., & Burn, D. J. (2011) · Movement Disorders · doi:10.1002/mds.23664 · Cited by 422 · see citing works

Medication-Related Impulse Control and Repetitive Behaviors in Parkinson Disease

Voon, V., & Fox, S. H. (2007) · Archives of Neurology · doi:10.1001/archneur.64.8.1089 · Cited by 397 · see citing works

Impulse control disorders and levodopa-induced dyskinesias in Parkinson's disease: an update

Voon, V., Napier, T. C., Frank, M. J., Sgambato, V., Grace, A. A., Rodríguez‐Oroz, M., Obeso, J. A., Bézard, E., & Fernagut, P. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30004-2 · Cited by 360 · see citing works

Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders

Voon, V., Fernagut, P., Wickens, J. R., Baunez, C., Rodríguez‐Oroz, M., Pavon, N., Juncos, J. L., Obeso, J. A., & Bézard, E. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70287-x · Cited by 352 · see citing works

Natural rewards, neuroplasticity, and non-drug addictions

Olsen, C. M. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.03.010 · Cited by 339 · see citing works

Personality, Addiction, Dopamine: Insights from Parkinson's Disease

Dagher, A., & Robbins, T. W. (2009) · Neuron · doi:10.1016/j.neuron.2009.01.031 · Cited by 339 · see citing works

Cue-induced striatal dopamine release in Parkinson's disease-associated impulsive-compulsive behaviours

O'Sullivan, S. S., Wu, K., Politis, M., Lawrence, A. D., Evans, A. H., Bose, S. K., Djamshidian, A., Lees, A. J., & Piccini, P. (2011) · Brain · doi:10.1093/brain/awr003 · Cited by 297 · see citing works

Mechanisms underlying dopamine-mediated reward bias in compulsive behaviors

Voon, V., Pessiglione, M., Brezing, C., Gallea, C., Fernandez, H. H., Dolan, R. J., & Hallett, M. (2010) · Neuron · doi:10.1016/j.neuron.2009.12.027 · Cited by 280 · see citing works

Evolving Concepts of Emotion and Motivation

Berridge, K. C. (2018) · Frontiers in Psychology · doi:10.3389/fpsyg.2018.01647 · Cited by 273 · see citing works

A reward-centred model of anorexia nervosa: A focussed narrative review of the neurological and psychophysiological literature

O'Hara, C., Campbell, I. C., & Schmidt, U. H. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.02.012 · Cited by 271 · see citing works

Impulse Control and Related Disorders in Parkinson's Disease

Weintraub, D. A., & Claassen, D. O. (2017) · International review of neurobiology · doi:10.1016/bs.irn.2017.04.006 · Cited by 273 · see citing works

Dopamine Dysregulation Syndrome: An Overview of its Epidemiology, Mechanisms and Management

OʼSullivan, S. S., Evans, A. H., & Lees, A. J. (2009) · CNS Drugs · doi:10.2165/00023210-200923020-00005 · Cited by 265 · see citing works

Neuroimaging in Parkinson disease: from research setting to clinical practice

Politis, M. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.205 · Cited by 247 · see citing works

Roles of "wanting" and "liking" in motivating behavior: gambling, food, and drug addictions

Robinson, M. J. F., Fischer, A. M., Ahuja, A., Lesser, E. N., & Maniates, H. (2015) · Current topics in behavioral neurosciences · doi:10.1007/7854_2015_387 · Cited by 247 · see citing works

Levodopa in the Treatment of Parkinson's Disease: Current Status and New Developments

Salat, D., & TOLOSA, E. S. (2013) · Journal of Parkinson s Disease · doi:10.3233/jpd-130186 · Cited by 243 · see citing works

Behavioral Addictions: An Overview

Karim, R., & Chaudhri, P. (2012) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2012.662859 · Cited by 239 · see citing works

Impulsive and compulsive behaviors in Parkinson's disease

Evans, A. H., Strafella, A. P., Weintraub, D. A., & Stacy, M. A. (2009) · Movement Disorders · doi:10.1002/mds.22505 · Cited by 233 · see citing works

Neuropsychiatric effects of subthalamic neurostimulation in Parkinson disease

Volkmann, J., Daniels, C., & Witt, K. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.111 · Cited by 232 · see citing works

Building a neuroscience of pleasure and well-being

Berridge, K. C., & Kringelbach, M. L. (2011) · Psychology of Well-Being: Theory, Research and Practice · doi:10.1186/2211-1522-1-3 · Cited by 229 · see citing works

Pathological gambling in Parkinson's disease: Risk factors and differences from dopamine dysregulation. An analysis of published case series

Gallagher, D. A., O’Sullivan, S. S., Evans, A. H., Lees, A. J., & Schrag, A. E. (2007) · Movement Disorders · doi:10.1002/mds.21611 · Cited by 224 · see citing works

Involvement of the subthalamic nucleus in impulse control disorders associated with Parkinson’s disease

Rodríguez‐Oroz, M., López‐Azcárate, J., García‐García, D., Alegre, M., Toledo, J. B., Valencia, M., Guridi, J., Artieda, J., & Obeso, J. A. (2010) · Brain · doi:10.1093/brain/awq301 · Cited by 223 · see citing works

Measuring wanting and liking from animals to humans: a systematic review

Pool, E., Sennwald, V., Delplanque, S., Brosch, T., & Sander, D. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.01.006 · Cited by 211 · see citing works

Striatal Dopamine and the Interface between Motivation and Cognition

Aarts, E., van Holstein, M., & Cools, R. (2011) · Frontiers in Psychology · doi:10.3389/fpsyg.2011.00163 · Cited by 211 · see citing works

New experimental and clinical links between the hippocampus and the dopaminergic system in Parkinson's disease

Calabresi, P., Castrioto, A., Filippo, M. D., & Picconi, B. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70118-2 · Cited by 211 · see citing works

Overview of the Extranigral Aspects of Parkinson Disease

Lim, S., Fox, S. H., & Lang, A. E. (2009) · Archives of Neurology · doi:10.1001/archneurol.2008.561 · Cited by 207 · see citing works

In vivo evidence for greater amphetamine-induced dopamine release in pathological gambling: a positron emission tomography study with [11C]-(+)-PHNO

Boileau, I., Payer, D., Chugani, B., Lobo, D. S. S., Houle, S., Wilson, A. A., Warsh, J., Kish, S. J., & Zack, M. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.163 · Cited by 198 · see citing works

Impulse control disorders in Parkinson's disease

Voon, V., Mehta, A. R., & Hallett, M. (2011) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3283489687 · Cited by 195 · see citing works

Dopamine and impulse control disorders in Parkinson's disease

Weintraub, D. A. (2009) · Annals of Neurology · doi:10.1002/ana.21454 · Cited by 189 · see citing works

Phasic dopamine release in appetitive behaviors and drug addiction

Wanat, M., Willuhn, I., Clark, J., & Phillips, P. (2009) · Current Drug Abuse Reviewse · doi:10.2174/1874473710902020195 · Cited by 177 · see citing works

Intact Reward Learning but Elevated Delay Discounting in Parkinson's Disease Patients With Impulsive-Compulsive Spectrum Behaviors

Housden, C. R., O’Sullivan, S. S., Joyce, E. M., Lees, A. J., & Roiser, J. P. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.84 · Cited by 176 · see citing works

Dopamine dysregulation syndrome in Parkinson’s disease: a systematic review of published cases

Warren, N., O’Gorman, C., Lehn, A., & Siskind, D. J. (2017) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2017-315985 · Cited by 175 · see citing works

Imaging biomarkers in Parkinson's disease.

Brooks, D., & Pavese, N. (2011) · Progress in neurobiology · doi:10.1016/j.pneurobio.2011.08.009 · Cited by 163 · see citing works

The nonmotor symptoms of Parkinson's disease—An overview

Lim, S., & Lang, A. E. (2010) · Movement Disorders · doi:10.1002/mds.22786 · Cited by 171 · see citing works

Striatal ups and downs: Their roles in vulnerability to addictions in humans

Leyton, M., & Vezina, P. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.01.018 · Cited by 165 · see citing works

New onset heightened interest or drive for gambling, shopping, eating or sexual activity in patients with Parkinson's disease: the role of dopamine agonist treatment and age at motor symptoms onset

Giladi, N., Weitzman, N., Schreiber, S., Shabtai, H., & Peretz, C. (2007) · Journal of Psychopharmacology · doi:10.1177/0269881106073109 · Cited by 164 · see citing works

Medication-related impulse control and repetitive behaviors in Parkinson??s disease

Voon, V., Potenza, M. N., & Thomsen, T. R. (2007) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32826fbc8f · Cited by 162 · see citing works

The Neuropsychiatry of Parkinson Disease: A Perfect Storm

Weintraub, D. A., & Mamikonyan, E. (2019) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2019.03.002 · Cited by 164 · see citing works

Reduced dopamine transporter density in the ventral striatum of patients with Parkinson's disease and pathological gambling

Cilia, R., Ko, J. H., Cho, S. S., van Eimeren, T., Marotta, G., Pellecchia, G., Pezzoli, G., Antonini, A., & Strafella, A. P. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.03.013 · Cited by 158 · see citing works

Dopamine and addiction: what have we learned from 40 years of research

Solinas, M., Belujon, P., Fernagut, P., Jaber, M., & Thiriet, N. (2018) · Journal of Neural Transmission · doi:10.1007/s00702-018-1957-2 · Cited by 155 · see citing works

Dopamine dysregulation syndrome, addiction and behavioral changes in Parkinson's disease

Merims, D., & Giladi, N. (2007) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2007.09.007 · Cited by 148 · see citing works

A systematic review of impulse control disorders in Parkinson’s disease.

Callesen, M. B., Scheel-Krüger, J., Kringelbach, M. L., & Møller, A. (2013) · Journal of Parkinson s Disease · doi:10.3233/jpd-120165 · Cited by 130 · see citing works

Compulsive features in behavioural addictions: the case of pathological gambling

el‐Guebaly, N., Mudry, T., Zohar, J., Tavares, H., & Potenza, M. N. (2011) · Addiction · doi:10.1111/j.1360-0443.2011.03546.x · Cited by 130 · see citing works

Conditioned and sensitized responses to stimulant drugs in humans

Leyton, M. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.08.027 · Cited by 127 · see citing works

“You Say it's Liking, I Say it's Wanting …”. On the difficulty of disentangling food reward in man

Havermans, R. C. (2011) · Appetite · doi:10.1016/j.appet.2011.05.310 · Cited by 125 · see citing works

The Incentive-Sensitization Theory of Addiction 30 Years On

Robinson, T. E., & Berridge, K. C. (2024) · Annual Review of Psychology · doi:10.1146/annurev-psych-011624-024031 · Cited by 137 · see citing works

Impulse control disorders in Parkinson's disease: definition, epidemiology, risk factors, neurobiology and management

Ceravolo, R., Frosini, D., Rossi, C. A., & Bonuccelli, U. (2009) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(09)70847-8 · Cited by 124 · see citing works

Implicit measures of “wanting” and “liking” in humans

Tibboel, H., Houwer, J. D., & Bockstaele, B. V. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.09.015 · Cited by 122 · see citing works

Dopamine turnover increases in asymptomatic LRRK2 mutations carriers

Sossi, V., de la Fuente‐Fernández, R., Nandhagopal, R., Schulzer, M., McKenzie, J., Ruth, T. J., Aasly, J. O., Farrer, M. J., Wszołek, Z. K., & Stoessl, A. J. (2010) · Movement Disorders · doi:10.1002/mds.23356 · Cited by 119 · see citing works

Can the neuroeconomics revolution revolutionize psychiatry?

Hasler, G. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.04.011 · Cited by 117 · see citing works

Hedonic Hotspots: Generating Sensory Pleasure in the Brain

Smith, K. S., Mahler, S. V., Peciña, S., & Berridge, K. C. (2009) · Oxford University Press eBooks · doi:10.1093/oso/9780195331028.003.0003 · Cited by 117 · see citing works

Molecular mechanisms underlying levodopa-induced dyskinesia

Calabresi, P., Filippo, M. D., Ghiglieri, V., & Picconi, B. (2008) · Movement Disorders · doi:10.1002/mds.22019 · Cited by 115 · see citing works

Levodopa-induced plasticity: a double-edged sword in Parkinson's disease?

Calabresi, P., Ghiglieri, V., Mazzocchetti, P., Corbelli, I., & Picconi, B. (2015) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2014.0184 · Cited by 114 · see citing works

Non-dopaminergic treatments in development for Parkinson's disease

Fox, S. H., Brotchie, J. M., & Lang, A. E. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70214-x · Cited by 112 · see citing works

Impulse Control and Related Disorders in Parkinson’s Disease

Weintraub, D. A., & Nirenberg, M. J. (2012) · Neurodegenerative Diseases · doi:10.1159/000341996 · Cited by 109 · see citing works

Influence of Compulsivity of Drug Abuse on Dopaminergic Modulation of Attentional Bias in Stimulant Dependence

Ersche, K. D., Bullmore, E. T., Craig, K. J., Shabbir, S. S., Abbott, S., Müller, U., Ooi, C., Suckling, J., Barnes, A., Sahakian, B. J., et al. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.60 · Cited by 108 · see citing works

Impulse Control Disorders in Parkinson's Disease. A Brief and Comprehensive Review

Gatto, E. M., & Aldinio, V. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00351 · Cited by 106 · see citing works

How central is dopamine to pathological gambling or gambling disorder?

Potenza, M. N. (2013) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2013.00206 · Cited by 103 · see citing works

Impulsivity and apathy in Parkinson's disease

Sinha, N., Manohar, S., & Masud Husain, B. (2013) · Journal of Neuropsychology · doi:10.1111/jnp.12013 · Cited by 104 · see citing works

Cerebral interactions of pain and reward and their relevance for chronic pain

Becker, S., Gandhi, W., & Schweinhardt, P. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.03.013 · Cited by 103 · see citing works

Decision making, impulsivity, and addictions: Do Parkinson's disease patients jump to conclusions?

Djamshidian, A., O’Sullivan, S. S., Sanotsky, Y., Sharman, S., Matviyenko, Y., Foltynie, T., Michalczuk, R., Avilés-Olmos, I., Fedoryshyn, L., Doherty, K. A., et al. (2012) · Movement Disorders · doi:10.1002/mds.25105 · Cited by 102 · see citing works

Impulse Control and Related Disorders in Parkinson's Disease

Lim, S., Evans, A. H., & Miyasaki, J. M. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1444.006 · Cited by 99 · see citing works

Impulse control disorders in Parkinson's disease: decreased striatal dopamine transporter levels

Voon, V., Rizos, A., Chakravartty, R., Mulholland, N. J. R., Robinson, S., Howell, N. A., Harrison, N. A., Vivian, G., & Chaudhuri, К. R. (2013) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2013-305395 · Cited by 99 · see citing works

Drug Insight: impulse control disorders and dopamine therapies in Parkinson's disease

Potenza, M., Voon, V., & Weintraub, D. (2007) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0680 · Cited by 94 · see citing works

Applying incentive sensitization models to behavioral addiction

Thomsen, K. R., Fjorback, L. O., Møller, A., & Lou, H. C. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.07.009 · Cited by 96 · see citing works

Imaging of compensatory mechanisms in Parkinson's disease

Appel‐Cresswell, S., de la Fuente‐Fernández, R., Galley, S., & McKeown, M. J. (2010) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32833b6019 · Cited by 92 · see citing works

A linear model for estimation of neurotransmitter response profiles from dynamic PET data

Normandin, M., Schiffer, W., & Morris, E. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.07.002 · Cited by 91 · see citing works

The role of learning-related dopamine signals in addiction vulnerability

Huys, Q. J. M., Tobler, P. N., Hasler, G., & Flagel, S. B. (2014) · Progress in brain research · doi:10.1016/b978-0-444-63425-2.00003-9 · Cited by 87 · see citing works

Management of psychiatric and cognitive complications in Parkinson’s disease

Weintraub, D. A., Aarsland, D., Biundo, R., Dobkin, R. D., Goldman, J. G., & Lewis, S. J. G. (2022) · BMJ · doi:10.1136/bmj-2021-068718 · Cited by 91 · see citing works

Risk and learning in impulsive and nonimpulsive patients with Parkinson's disease

Djamshidian, A., Jha, A., O’Sullivan, S. S., Silveira‐Moriyama, L., Jacobson, C., Brown, P., Lees, A. J., & Averbeck, B. B. (2010) · Movement Disorders · doi:10.1002/mds.23247 · Cited by 90 · see citing works

The prevalence and clinical characteristics of punding in Parkinson's disease

Spencer, A., Rickards, H. E., Fasano, A. A., & Cavanna, A. E. (2011) · Movement Disorders · doi:10.1002/mds.23508 · Cited by 86 · see citing works

Systematic Review on Parkinson’s Disease Medications, Emphasizing on Three Recently Approved Drugs to Control Parkinson’s Symptoms

Sivanandy, P., Tan, C. L., Xiang, T. C., Ling, T. C., Han, S. A. W., Semilan, S. L. A., & Hong, P. K. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19010364 · Cited by 86 · see citing works

Parkinson’s disease-related disorders in the impulsive-compulsive spectrum

Wolters, E. C., van der Werf, Y. D., & van den Heuvel, O. A. (2008) · Journal of Neurology · doi:10.1007/s00415-008-5010-5 · Cited by 85 · see citing works

Behavioral effects of levodopa

Beaulieu‐Boire, I., & Lang, A. E. (2014) · Movement Disorders · doi:10.1002/mds.26121 · Cited by 83 · see citing works

Amphetamine Sensitization Alters Reward Processing in the Human Striatum and Amygdala

O'Daly, O., Joyce, D., Tracy, D., Azim, A., Stephan, K., Murray, R., & Shergill, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093955 · Cited by 84 · see citing works

Do dyskinesia and pain share common pathophysiological mechanisms in Parkinson's disease?

Lim, S., Farrell, M. J., Gibson, S. J., Helme, R. D., Lang, A. E., & Evans, A. H. (2008) · Movement Disorders · doi:10.1002/mds.22111 · Cited by 83 · see citing works

Apathy and Impulse Control Disorders: Yin & Yang of Dopamine Dependent Behaviors

Sierra, M., Carnicella, S., Strafella, A. P., Bichon, A., Lhommée, E., Castrioto, A., Chabardès, S., Thobois, S., & Krack, P. (2015) · Journal of Parkinson s Disease · doi:10.3233/jpd-150535 · Cited by 83 · see citing works

Nonmotor Manifestations in Parkinson Disease

Bernal-Pacheco, Ó., Limotai, N., Go, C. L., & Fernandez, H. H. (2012) · The Neurologist · doi:10.1097/nrl.0b013e31823d7abb · Cited by 81 · see citing works

Differential nicotinic regulation of the nigrostriatal and mesolimbic dopaminergic pathways: Implications for drug development

Janhunen, S. K., & Ahtee, L. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2006.09.008 · Cited by 81 · see citing works

Binge Eating in Parkinson's Disease: Prevalence, Correlates and the Contribution of Deep Brain Stimulation

Zahodne, L. B., Susatia, F., Bowers, D., Ong, T. L., Jacobson, C. E., Okun, M. S., Rodriguez, R. L., Malaty, I. A., Foote, K. D., & Fernandez, H. H. (2011) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.23.1.56 · Cited by 82 · see citing works

Characteristics of the sequence effect in Parkinson's disease

Kang, S. Y., Wasaka, T., Shamim, E. A., Auh, S., Ueki, Y., Lopez, G. J., Kida, T., Jin, S., Dang, N., & Hallett, M. (2010) · Movement Disorders · doi:10.1002/mds.23251 · Cited by 81 · see citing works

Novelty seeking behaviour in Parkinson's disease

Djamshidian, A., O’Sullivan, S. S., Wittmann, B. C., Lees, A. J., & Averbeck, B. B. (2011) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2011.04.026 · Cited by 81 · see citing works

Substance Abuse and Movement Disorders: Complex Interactions and Comorbidities

Deik, A., Saunders-Pullman, R. J., & Luciano, M. S. (2012) · Current Drug Abuse Reviews · doi:10.2174/1874473711205030243 · Cited by 80 · see citing works

The dopaminergic hypothesis of attention-deficit/hyperactivity disorder needs re-examining

Gonon, F. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2008.09.010 · Cited by 79 · see citing works

Beer Flavor Provokes Striatal Dopamine Release in Male Drinkers: Mediation by Family History of Alcoholism

Oberlin, B. G., Džemidžić, M., Tran, S. M., Soeurt, C. M., Albrecht, D., Yoder, K. K., & Kareken, D. A. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.91 · Cited by 79 · see citing works

[ 11 C]‐(+)‐PHNO PET imaging of dopamine D 2/3 receptors in Parkinson's disease with impulse control disorders

Payer, D. E., Guttman, M., Kish, S. J., Tong, J., Strafella, A. P., Zack, M. H., Adams, J. R., Rusjan, P., Houle, S., Furukawa, Y., et al. (2015) · Movement Disorders · doi:10.1002/mds.26135 · Cited by 78 · see citing works

Dopamine ‘ups and downs’ in addiction revisited

Samaha, A., Khoo, S. Y., Ferrario, C. R., & Robinson, T. E. (2021) · Trends in Neurosciences · doi:10.1016/j.tins.2021.03.003 · Cited by 77 · see citing works

Invited Article: Functional imaging in Parkinson disease

Nandhagopal, R., McKeown, M. J., & Stoessl, A. J. (2008) · Neurology · doi:10.1212/01.wnl.0000310432.92489.90 · Cited by 77 · see citing works

Hypomania and mania related to dopamine replacement therapy in Parkinson's disease

Maier, F., Merkl, J., Ellereit, A. L., Lewis, C. J., Eggers, C., Pedrosa, D. J., Kalbe, E., Kuhn, J., Meyer, T. D., Zurowski, M., et al. (2014) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2014.01.001 · Cited by 76 · see citing works

Dopamine Circuit Mechanisms of Addiction-Like Behaviors

Poisson, C. L., Engel, L., & Saunders, B. T. (2021) · Frontiers in Neural Circuits · doi:10.3389/fncir.2021.752420 · Cited by 75 · see citing works

Compulsive Drug Use Linked to Sensitized

Striatal, V., Transmission, D., & Piccini, P. P. (2014)

Compulsive use of dopaminergic drugs in Parkinson's disease.

Evans, A. H. (2008) · UCL Discovery (University College London)

Compulsive use of dopaminergic drugs in Parkinson's disease : a window into the role of dopamine in addiction and impulse control disorders

Evans, A. H. (2008) · OpenGrey (Institut de l'Information Scientifique et Technique)

Compulsive use of dopaminergic drug therapy in Parkinson's disease: Reward and anti‐reward

Evans, A. H., Lawrence, A. D., Cresswell, S. A., Katzenschlager, R., & Lees, A. J. (2010) · Movement Disorders · doi:10.1002/mds.22898 · Cited by 51 · see citing works

Cue-induced striatal dopamine release in Parkinson's disease-associated impulsive-compulsive behaviours

O'Sullivan, S. S., Wu, K., Politis, M., Lawrence, A. D., Evans, A. H., Bose, S. K., Djamshidian, A., Lees, A. J., & Piccini, P. (2011) · Brain · doi:10.1093/brain/awr003 · Cited by 297 · see citing works